IPP Seminar
When
Event Details
26th November at 14:00
Onsite event
Aistikattila, Medisiina C
Coffee/tea will be served at 13:45
Prof. Christa Maes, KU Leuven, Belgium
Bone crosstalk with energy metabolism: Roles of skeletal cells and hypoxia signaling in the regulation of glucose homeostasis.
Host: Kaisa Ivaska (kaisa.ivaska@utu.fi)
Note: Prof. Maes will serve as the opponent at the doctoral defense of Nicko Widjaja on Friday 27th November (Medisiina C, Osmo Järvi lecture room at 12:00).
Christa Maes is Professor at KU Leuven (Belgium), at the Skeletal Biology and Engineering Research Center, Department of Development and Regeneration. Her laboratory aims to gain insights in the genetic and molecular control of bone cell functioning. They focus on skeletal stem/progenitor cells (SSPCs) and osteoblasts, their interplay with the bone vasculature, and their roles in the broader physiological context of the organism. Prime working models are genetically modified mice, including conditional knockout mice and in vivo lineage tracing models using fluorescent reporter strains, as well as in vitro and molecular methods. Through the research, they hope to contribute to basic bone biology and to the future development of new osteoanabolic drugs and regenerative approaches for skeletal tissue repair. In addition, insights in the integrative physiology involving bone may help discover therapeutic approaches that link bone and other problems, such as osteoporosis, obesity and diabetes, in progressively growing groups of patients.
Selected publications
Valle-Tenney R, Peredo N, De Samblancx K, Nefyodova E, Cardoen R, Dehaemers T, Farlay D, Chapurlat R, Van der Schueren B, Mathieu C, Vangoitsenhoven R, Maes C. (2026). Pharmacological HIF activation protects against diet-induced obesity, glucose intolerance, and skeletal dysfunction by exerting dual beneficial effects on energy metabolism and bone. Bone Res. 14 (1): 21.
Melis S, Dirckx N, De Samblancx K, Valle-Tenney R, Provot S, Vanderschueren D, Dubois V, Maes C. (2025) Hypoxia signaling pathway activation in osteoblasts suppresses osteocalcin production but does not alter male fertility in mice. Eur J Endocrinol. Nov 26;193(6):679-693.
Melis, S., Trompet, D., Chagin, A.S., and Maes, C. (2025). Skeletal stem and progenitor cells in bone physiology, ageing and disease. Nat Rev Endocrinol. 2025 Mar; 21(3): 135-153.
Trompet D.*, Melis S.*, Chagin A.S., Maes C. (2024). Skeletal stem and progenitor cells in bone development and repair. J Bone Miner Res., 2024 Jul 23; 39(6): 633-654. doi: 10.1093/jbmr/zjae069.
Mesnieres, M., Böhm, A.M., Peredo, N., Trompet, D., Valle-Tenney, R. Bajaj, M., Corthout, N., Nefyodova, E., Cardoen, R., Baatsen, P., Munck, S., Nagy, A., Haigh, J.J., Khurana, S., Verfaillie, C.M., Maes, C. (2021). Fetal hematopoietic stem cell homing is controlled by VEGF regulating the integrity and oxidative status of the stromal-vascular bone marrow niches. Cell Reports, 36, 109618.